ClinicalTrials.Veeva

Menu

Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study

F

Fayoum University

Status

Completed

Conditions

Oral Squamous Cell Carcinoma
Oral Cancer

Treatments

Diagnostic Test: ELISA

Study type

Observational

Funder types

Other

Identifiers

NCT06031337
1591985

Details and patient eligibility

About

The study will include patients with oral cancer and healthy controls of both sexes. Subjects having any systemic diseases or other types of cancer will be excluded. All subjects will be selected from Oral Medicine Department, Faculty of Dentistry, Al Ahram Canadian University and Fayoum University. Informed consent will be obtained from all subjects enrolled in this study after explanation of the whole procedure.

Enrollment

46 patients

Sex

All

Ages

12+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • patients with oral cancer

Exclusion criteria

  • any systemic diseases or other types of cancer will be excluded

Trial design

46 participants in 2 patient groups

Oral Cancer Group
Description:
23 patients with oral cancer
Treatment:
Diagnostic Test: ELISA
Control Group
Description:
23 age-and-sex-matched healthy individuals, as normal controls
Treatment:
Diagnostic Test: ELISA

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems